The NEC1452 PDX tumor sample did not match any pre-existing samples in the IDEXX DSMZ STR database (Supplementary Table S4), and exome sequencing confirmed TP53 stopgain mutations and RB1 frameshift mutation (Figure 1C, Supplementary Table S2). Here, RB1 is linked to neoplasm.